Trophos awarded US patent covering use of novel cardioprotective compound

Links shared publicly online about this topic.

51
total visits

Trophos awarded US patent covering use of novel cardioprotective compound

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for the use of their novel mitochondrial pore modulator, TRO40303, for cytoprotection. The patent provides coverage for the use of Trophos’ TRO40303 to reduce the cardiac reperfusion injury that contributes sign

View full resource at news-medical.net

Tags: Heart, Neurology, Pharma, Cardiology